Skip to content
All bills in Congress

S. 641 · 119th Congress · Health

Safe and Affordable Drugs from Canada Act of 2025

A bill that started in the Senate. To become law it must pass the Senate and the House in identical form and be signed by the President.

Where it stands

In committee in the Senate

  1. Introduced — doneFeb 19, 2025
  2. Committee — not yet
  3. Passed the Senate — not yet
  4. Passed the House — not yet
  5. Sent to the President — not yet
  6. Became law — not yet

Latest action · Feb 19, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

What this bill means

In plain English

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

From the official summary by the Congressional Research Service (introduced in senate version). The full summary is below.

If it passes

It becomes federal law, and what it describes takes effect on the dates written into the bill.

What still has to happen

  1. 1A Senate committee must take it up and approve it. Most bills never get past this step.
  2. 2Then the full Senate must pass it.
  3. 3Then the House must pass it in the same form.
  4. 4Then it goes to the President to sign or veto.

If it doesn't pass

  • Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
  • This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in Senate · Feb 19, 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

Who started it

Sponsor — the member who introduced it

Amy Klobuchar

DemocratSenator from Minnesota

Introduced in the Senate on Feb 19, 2025.

See Amy Klobuchar's votes and donors

Cosponsors — members who signed on in support

8cosponsors

6 Democrats · 1 Republican · 1 other

Members of both parties have signed on.

Committees handling it

A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.

  • Health, Education, Labor, and Pensions Committee

    Senate

    • Referred To · Feb 19, 2025
    • Referred To · Feb 19, 2025

Full timeline

Every recorded action on S. 641, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.

  1. IntroducedSenate

    Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Have a view on S. 641? Your leaders vote on it.

Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.

Write your leaders about thisSource: Congress.gov record for S. 641(opens in new tab)